Key result
Adolescent cardiovascular prevention is critical to curb projected EU disability costs exceeding ~€190 million annually.
Why the study?
Despite improvements in medical treatments, cardiovascular disease remains the leading cause of premature mortality and a major source of chronic disability, necessitating a focus on population-level prevention strategies starting in adolescence.
Major improvements in medical treatments over the past half century have resulted in more people than ever surviving with cardiovascular disease (CVD). Despite these successes, however, CVD remains not only the world’s largest cause of premature mortality, but also a major cause of chronic disability affect many living with the disease. With estimated costs for this disability burden predicted to account for over €190million a year in the EU alone, it is clear that a focus on population-level prevention strategies – rather than attempts to simply cure end-stage disease – are essential if the increases in longevity and quality-of-life achieved in recent decades are to be maintained.
No takes yet. Share an insight, caveat, or question.
Chiesa et al. (2019) conducted an editorial in Cardiovascular disease. Population-level cardiovascular prevention strategies in adolescence was evaluated. Population-level prevention strategies starting in adolescence are essential to address future cardiovascular disability, which is predicted to cost over €190 million a year in the EU alone.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: